Position in GANX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$196,936
-$24,217 QoQ
Shares Held
97,013
-14.9% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 49 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,537,836 across 424 Biotechnology names. GANX ranks #316 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in GANX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,936 | 97,013 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $221,153 | 113,997 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $328,442 | 102,001 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $156,465 | 88,399 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $180,306 | 100,170 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $191,324 | 100,170 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $182,704 | 84,586 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $80,000 | 44,944 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $57,527 | 44,944 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $175,251 | 46,486 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $142,069 | 43,513 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,548 | 13,277 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $59,480 | 13,277 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $63,995 | 13,277 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $39,268 | 12,546 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $40,899 | 12,546 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||